Bolt Biotherapeutics
BOLT6.27049.64% ( +2.080 )
Bolt Biotherapeutics (BOLT)
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company’s pipeline produ...
- Open
- 6.980
- High
- 7.780
- Low
- 5.990
- Prev. Close
- 4.190
- Volume
- 12.88M
- Turnover
- 89.65M
- Avg Price
- 6.959
- Bid/Ask Ratio
- --
- Amplitude
- 42.72%
- 52wk High
- 7.780
- Volume Ratio
- 963.93
- Turnover Ratio
- 794.48%
- 52wk Low
- 3.100
- Float Mkt Cap
- 10.17M
- Market CapUSD
- 12.08M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -14.92
- EPSDynamic
- -15.54
- EPSStatic
- --
- BVPS
- 6.56
- P/B
- 0.96
- Circulating Supply
- 1.62M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 1.93M
- Min lot size
- 1
- Currency
- USD
Bolt Biotherapeutics Analyst Rating
View moreForecast & Rating
Oct 23, 2026Price forecast
$41.00553.91%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks ·
Why Is Penny Stock Bolt Biotherapeutics (BOLT) Up 62% Today?
- benzinga_article ·
12 Health Care Stocks Moving In Friday's Intraday Session
- StockTitan ·
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications | BOLT Stock News
- Market Movers ·
Bolt Biotherapeutics soars 57% during regular trading
